3 medicines removed from HRT PPC list from 1 August 2024

Pharmacy teams should be aware that the following three HRT medicines have been discontinued and will be removed from the list of medicines covered by the HRT PPC on 1 August 2024:

• Bedol^® 2mg tablets
• Climanor^® 5mg tablets
• Clinorette^® tablets

As Climanor^® 5mg tablets is now discontinued, the generic Medroxyprogesterone 5mg tablets will also be removed from the HRT PPC list as this product is no longer available as a licensed HRT medicine (note: the brand Provera^® 5mg tablets is NOT a licensed HRT medicine and therefore is not covered by the HRT PPC).

Pharmacy staff are advised to check the NHS Business Services Authority (NHSBSA) website for an up-to-date list of HRT medicines covered by the HRT PPC. Community Pharmacy England has updated its HRT PPC medicines list to reflect the changes taking effect from August 2024. Please note: you may need to hard refresh (press Ctrl+R) to refer to the most up-to-date version. The list of HRT medicines covered by the HRT PPC will also be updated in Part XVI of the August 2024 Drug Tariff.

The HRT medicines list has been compiled following consultation with the Medicines and Healthcare products Regulatory Agency (MHRA), NHSBSA and the NHS England Menopause Clinical Reference Group. The list will be updated as new HRT medicines licensed for the treatment of menopause become available in the UK or as existing HRT medicines are discontinued from the UK market. If a product that meets the criteria is missing from the HRT medicines list please contact dhsc.publicenquiries@dhsc.gov.uk.

For further information on HRT PPCs please refer to CPE’s HRT PPC hub page.